Literature DB >> 22886255

Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.

Greg Hussack1, Mehdi Arbabi-Ghahroudi, C Roger Mackenzie, Jamshid Tanha.   

Abstract

Camelidae single-domain antibodies (VHHs) are a unique class of small binding proteins that are promising inhibitors of targets relevant to infection and immunity. With VHH selection from hyperimmunized phage display libraries now routine and the fact that VHHs possess long, extended complementarity-determining region (CDR3) loop structures that can access traditionally immunosilent epitopes, VHH-based inhibition of targets such as bacterial toxins are being explored. Toxin A and toxin B are high molecular weight exotoxins (308 kDa and 269 kDa, respectively) secreted by Clostridium difficile that are the causative agents of C. difficile-associated diseases in humans and in animals. Here, we provide protocols for the rapid generation of C. difficile toxin A- and toxin B-specific VHHs by llama immunization and recombinant antibody/phage display technology approaches and for further characterization of the VHHs with respect to toxin-binding affinity and specificity and the conformational nature of their epitopes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886255     DOI: 10.1007/978-1-61779-968-6_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.

Authors:  Zhiyong Yang; Diane Schmidt; Weilong Liu; Shan Li; Lianfa Shi; Jinliang Sheng; Kevin Chen; Hua Yu; Jacqueline M Tremblay; Xinhua Chen; Kurt H Piepenbrink; Eric J Sundberg; Ciaran P Kelly; Guang Bai; Charles B Shoemaker; Hanping Feng
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

2.  Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Yongrong Zhang; Gregorio Perez-Cordon; Tuxiong Huang; Jeremy Ramsey; Numan Oezguen; Tor C Savidge; Hanping Feng
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

3.  Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile.

Authors:  Tomohiko Murase; Luiz Eugenio; Melissa Schorr; Greg Hussack; Jamshid Tanha; Elena N Kitova; John S Klassen; Kenneth K S Ng
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

4.  Llama DNA Immunization and Isolation of Functional Single-Domain Antibody Binders.

Authors:  Frédéric Trempe; Martin A Rossotti; Tahir Maqbool; C Roger MacKenzie; Mehdi Arbabi-Ghahroudi
Journal:  Methods Mol Biol       Date:  2022

5.  Generation of synthetic nanobodies against delicate proteins.

Authors:  Iwan Zimmermann; Pascal Egloff; Cedric A J Hutter; Benedikt T Kuhn; Philipp Bräuer; Simon Newstead; Roger J P Dawson; Eric R Geertsma; Markus A Seeger
Journal:  Nat Protoc       Date:  2020-04-08       Impact factor: 13.491

Review 6.  An update on antibody-based immunotherapies for Clostridium difficile infection.

Authors:  Greg Hussack; Jamshid Tanha
Journal:  Clin Exp Gastroenterol       Date:  2016-08-01

7.  Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease.

Authors:  Hiba Kandalaft; Greg Hussack; Annie Aubry; Henk van Faassen; Yonghong Guan; Mehdi Arbabi-Ghahroudi; Roger MacKenzie; Susan M Logan; Jamshid Tanha
Journal:  Appl Microbiol Biotechnol       Date:  2015-05-05       Impact factor: 4.813

Review 8.  Single Domain Antibodies as New Biomarker Detectors.

Authors:  Chiuan Herng Leow; Katja Fischer; Chiuan Yee Leow; Qin Cheng; Candy Chuah; James McCarthy
Journal:  Diagnostics (Basel)       Date:  2017-10-17

9.  Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2.

Authors:  Chiuan Herng Leow; Martina Jones; Qin Cheng; Stephen Mahler; James McCarthy
Journal:  Malar J       Date:  2014-07-18       Impact factor: 2.979

10.  Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody.

Authors:  Traian Sulea; Greg Hussack; Shannon Ryan; Jamshid Tanha; Enrico O Purisima
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.